Homozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Leukemia & lymphoma Année : 2022

Homozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas

Résumé

The 3' regulatory region (3'RR) located downstream from the Cα gene is the conductor of transcription, accessibility, and remodeling of the IgH locus at mature B-cell stages. Convincing demonstrations of the essential contributions of the 3'RR in B-cell lymphomagenesis have been provided by mouse models which bring the oncogene c-Myc under the 3'RR transcriptional control. In this study, we developed a mouse model of CD138+ plasma B-cell lymphomas. If the KI of c-myc directly into Cα just 5' to the 3'RR in iMycCα mice produced B-cell lymphomas with low kinetics, we enforced c-myc production in iMycCα mice by the generation of homozygous c-myc transgenic mice. Our results show that homozygous iMycCα mice lead to a mouse model of plasma CD138+ B-cell lymphomas with interesting and wide transcriptomic similarities to human multiple myeloma and appropriated emergence kinetics that can be used to test new experimental therapeutic approaches.

Domaines

Immunologie

Dates et versions

hal-03825747 , version 1 (23-10-2022)

Identifiants

Citer

Melissa Ferrad, Nour Ghazzaui, Hussein Issaoui, Emilie Drouineau, Christelle Oblet, et al.. Homozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas. Leukemia & lymphoma, 2022, 63 (9), pp.2114-2125. ⟨10.1080/10428194.2022.2064989⟩. ⟨hal-03825747⟩
58 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More